Status:
COMPLETED
Importance of Core Stability for Coordinated Movement of the Human Body in Stroke Rehabilitation
Lead Sponsor:
Anna Olczak
Conditions:
Stroke
Eligibility:
All Genders
22-83 years
Phase:
NA
Brief Summary
This is an observational study. Measurements were made during two different motor tasks: trunk tilts without and with the tension of the abdominal muscles in the sitting position and walking in a plac...
Detailed Description
Surface electrodes (single-use 55 and 40 mm; ECG Electrodes; Sorimex, Poland) were glued to the subject's body according to the SENIAM (Surface ElectroMyoGraphy for the Non-Invasive Assessment of Musc...
Eligibility Criteria
Inclusion
- Main criteria for stroke group inclusion: 1) patients with ischemic stroke; 2) patients with hemiparesis after 5 to 7 week after stroke; 3) subjects with stable trunk (the Trunk Control Test 70-100 points); 4) subjects who were in a functional state allowing walking (Rankin Scale ≤ 3); 5) no severe deficits in communication, memory, or understanding what can impede proper measurement performance; 6) at least 22 years of age; maximum 83 years of age.
- Main criteria for stroke group exclusion: 1) stroke up to five weeks after the episode, 2) epilepsy, 3) lack of trunk stability, 4) lack of independent walking, 5) high or very low blood pressure, dizziness, malaise.
- Main criteria for control group inclusion: 1) the control group consisted of subjects with stable trunk (TCT 100 points); correct muscle tension (MAS 0), independent walking; 2) at least 22 years of age; maximum 83 years of age.
- Criteria for control group exclusion: 1) a history of neurologic or musculoskeletal disorders such as stroke or brain injury or other conditions that could affect their ability to active movement the trunk and the legs; 2) back pain; 3) no severe deficits in communication, memory, or understanding what can impede proper measurement performance; 4) high or very low blood pressure, dizziness, malaise.
Exclusion
Key Trial Info
Start Date :
August 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2019
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04886466
Start Date
August 10 2019
End Date
November 15 2019
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anna Olczak
Warsaw, Masovian District, Poland, 04-141